Literature DB >> 17490952

Histamine and histamine intolerance.

Laura Maintz1, Natalija Novak.   

Abstract

Histamine intolerance results from a disequilibrium of accumulated histamine and the capacity for histamine degradation. Histamine is a biogenic amine that occurs to various degrees in many foods. In healthy persons, dietary histamine can be rapidly detoxified by amine oxidases, whereas persons with low amine oxidase activity are at risk of histamine toxicity. Diamine oxidase (DAO) is the main enzyme for the metabolism of ingested histamine. It has been proposed that DAO, when functioning as a secretory protein, may be responsible for scavenging extracellular histamine after mediator release. Conversely, histamine N-methyltransferase, the other important enzyme inactivating histamine, is a cytosolic protein that can convert histamine only in the intracellular space of cells. An impaired histamine degradation based on reduced DAO activity and the resulting histamine excess may cause numerous symptoms mimicking an allergic reaction. The ingestion of histamine-rich food or of alcohol or drugs that release histamine or block DAO may provoke diarrhea, headache, rhinoconjunctival symptoms, asthma, hypotension, arrhythmia, urticaria, pruritus, flushing, and other conditions in patients with histamine intolerance. Symptoms can be reduced by a histamine-free diet or be eliminated by antihistamines. However, because of the multifaceted nature of the symptoms, the existence of histamine intolerance has been underestimated, and further studies based on double-blind, placebo-controlled provocations are needed. In patients in whom the abovementioned symptoms are triggered by the corresponding substances and who have a negative diagnosis of allergy or internal disorders, histamine intolerance should be considered as an underlying pathomechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490952     DOI: 10.1093/ajcn/85.5.1185

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  137 in total

1.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

2.  Allergic predisposition, histamine and histamine receptor expression (H1R, H2R) are associated with complicated courses of sigmoid diverticulitis.

Authors:  Burkhard H A von Rahden; Christian Jurowich; Stefan Kircher; Maria Lazariotou; Matthias Jung; Christoph-Thomas Germer; Martin Grimm
Journal:  J Gastrointest Surg       Date:  2011-09-29       Impact factor: 3.452

3.  Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Authors:  Hirokazu Sato; Linda S Zhang; Kristina Martinez; Eugene B Chang; Qing Yang; Fei Wang; Philip N Howles; Ryota Hokari; Soichiro Miura; Patrick Tso
Journal:  Gastroenterology       Date:  2016-07-18       Impact factor: 22.682

4.  Benign pancreatic hyperenzymemia (Gullo syndrome), histamine intolerance, and carbohydrate malabsorption.

Authors:  Wolfgang J Schnedl; Dietmar Enko; Harald Mangge; Michael Schenk; Sonja Lackner; Sandra J Holasek
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

5.  In vivo histamine voltammetry in the mouse premammillary nucleus.

Authors:  Srimal Samaranayake; Aya Abdalla; Rhiannon Robke; Kevin M Wood; Anisa Zeqja; Parastoo Hashemi
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

6.  Genetic Variation along the Histamine Pathway in Children with Allergic versus Nonallergic Asthma.

Authors:  Sara Anvari; Carrie A Vyhlidal; Hongying Dai; Bridgette L Jones
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

Review 7.  Histamine intolerance: a metabolic disease?

Authors:  H G Schwelberger
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

Review 8.  Mast cell and T cell communication; amplification and control of adaptive immunity.

Authors:  Alon Y Hershko; Juan Rivera
Journal:  Immunol Lett       Date:  2009-11-10       Impact factor: 3.685

9.  [Histamine intolerance mimics anorexia nervosa].

Authors:  I Stolze; K-P Peters; R A Herbst
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

10.  Serum diamine oxidase activity in patients with histamine intolerance.

Authors:  G Manzotti; D Breda; M Di Gioacchino; S E Burastero
Journal:  Int J Immunopathol Pharmacol       Date:  2015-11-16       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.